Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Infectious Diseases|September 1, 1992
Monitoring of antibodies against human immunodeficiency virus type 1 p25 core protein as prognostic markerE Fenouillet, N Blanes, A Coutellier, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|December 1, 1998
Properties of HIV envelope expressed in the presence of SPC3, an Env-derived peptide drug under phase II clinical trialsR Barbouche, E Fenouillet, M J Papandréou, et al.
The Journal of Experimental Medicine|March 1, 1989
Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysisE Fenouillet, B Clerget-Raslain, J C Gluckman, et al.
Virology|September 15, 1996
Anti-HIV activity of multibranched peptide constructs derived either from the cleavage sequence or from the transmembrane domain (gp41) of the human immunodeficiency virus type 1 envelopeJ M Sabatier, K Mabrouk, M Moulard, et al.
Journal of Virology|January 1, 1993
Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomainE Fenouillet, I Jones, B Powell, et al.
Endocrinology|June 1, 1988
Polymorphism of prolactin secreted by human prolactinoma cells: immunological, receptor binding, and biological properties of the glycosylated and nonglycosylated formsI Pellegrini, G Gunz, C Ronin, et al.
FEBS Letters|August 19, 1996
Novel anti-platelet aggregation polypeptides from Vipera lebetina venom: isolation and characterizationR Barbouche, N Marrakchi, P Mansuelle, et al.
The Journal of General Virology|November 1, 1994
Extensive C-terminal deletion in human immunodeficiency virus type 1 Env glycoprotein arising after long-term culture of chronically infected cellsV Zaides, M Yagello, T Veselovskaya, et al.
AIDS (London, England)|November 1, 1990
Early and specific diagnosis of seropositivity to HIVs by an enzyme-linked immunosorbent assay using env-derived synthetic peptidesE Fenouillet, A M Sorensen, M Lacroix, et al.
Toxicon : Official Journal of the International Society on Toxinology|December 5, 1998
Anti-platelet activity of the peptides composing the lebetin 1 family, a new class of inhibitors of platelet aggregationR Barbouche, N Marrakchi, K Mabrouk, et al.
Pageof 5